Cencora, Inc. (COR) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, an...
Cencora, Inc. (COR) currently trades at a P/E ratio of 24.56 (historical range: 19.37–44.79, median: 31.24), placing it at the 22th percentile — below its historical average, P/S ratio of 0.19 (range: 0.14–0.23, 73th percentile — above its historical average), EV/EBITDA of 38.26 (range: 20.79–103.83, 72th percentile).
Cencora, Inc. appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 24.56 | 19.37 | 31.24 | 44.79 | 22th | below its historical average |
| P/S Ratio | 0.19 | 0.14 | 0.18 | 0.23 | 73th | above its historical average |
| EV/EBITDA | 38.26 | 20.79 | 34.44 | 103.83 | 72th | above its historical average |
| FCF Yield | 0.05 | 0.01 | 0.05 | 0.07 | 65th | below its historical average |